Empyrean Lifesciences Private Limited, a active private limited company, was established on 19 June 2014 in Shaikpet, Telangana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232MH2014PTC367624. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.10 M.
Formerly known as Epione Formulations Private Limited, Empyrean Lifescience Private Limited. It upholds a compliant status. Employing 32 professional, Its leadership includes Sailesh Jhawar Kumar (Director), Venkateswaran Nagraj Iyer (Director). Past directors included Krishna Yeachuri, Amit Purushottam Kaptain, Renuka Rao Rajender. It holds ₹300.00 Cr open charges and ₹6.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 2Nd Floor Jubilee Heights, Jubilee Enclave, Shaikpet, Telangana, 500081.
U24232TS2014PTC196113
196113
19 June 2014
₹5.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Empyrean Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sailesh Jhawar Kumar | Director | 01 Sep 2022 | Current |
| Venkateswaran Nagraj Iyer | Director | 31 Dec 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Dec 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Nov 2021 | Past |
| Pramod Abcsdd | Director | 02 Aug 2021 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Empyrean Lifesciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 98.62% decrease. The company also saw a substantial fall in profitability, with a 198.67% decrease in profit. The company's net worth observed a substantial decline by a decrease of 262.17%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Empyrean Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,000,000,000.00
₹60,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Sep 2024 | Others | ₹300.00 Cr | Open |
| 28 Feb 2020 | Others | ₹6.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Empyrean Lifesciences has a workforce of 32 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Empyrean Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Empyrean Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Empyrean Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
A charge with Others amounted to Rs. 3,000.00 M with Charge ID 101010786 was registered on 26 Sep 2024. was recorded as a recent event.
Empyrean Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
The activity Venkateswaran Nagraj Iyer was appointed as a Director was appointed as a Director on 31 Dec 2022 & has been associated with this company since 2 years 10 months . was completed.
Sailesh Jhawar Kumar was appointed as a Director was appointed as a Director on 01 Sep 2022 & has been associated with this company since 3 years 2 months . was recorded as a recent event.
Progress on A charge registered on 28 Feb 2020 via Charge ID 100329181 with Others was fully satisfied on 02 Jul 2020. was documented.
The CIN of Empyrean Lifesciences Private Limited is U24232TS2014PTC196113.
Empyrean Lifesciences Private Limited is headquartered at 2Nd Floor Jubilee Heights, Jubilee Enclave, Shaikpet, Telangana, 500081.
Empyrean Lifesciences Private Limited was incorporated on 19 June 2014.
The current directors of Empyrean Lifesciences Private Limited are
The primary industry of Empyrean Lifesciences Private Limited is Trade.
Empyrean Lifesciences Private Limited is unlisted.
The authorized capital of Empyrean Lifesciences Private Limited is ₹5.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Empyrean Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX